Croscarmellose Sodium (CCS) Market Growth Fueled by Tablet Disintegration Innovations
%20Market.jpg)
The global croscarmellose sodium market is set to enter a dynamic phase of growth over the coming decade, driven by increasing applications in the pharmaceutical industry. Valued at US$ 288.7 million in 2025, the market is projected to reach US$ 487.0 million by 2032, recording a robust compound annual growth rate (CAGR) of 7.8% between 2025 and 2032. This strong trajectory underscores the rising demand for pharmaceutical excipients that enable efficient drug delivery and enhance the performance of oral solid dosage forms. Croscarmellose sodium, widely recognized as a super disintegrant, is extensively used in tablets and capsules to facilitate rapid disintegration and improve drug bioavailability. Its unique ability to absorb water and swell enables the breakdown of solid dosage forms within minutes, making it a critical excipient in modern drug formulations. The growing global demand for generic drugs, coupled with the expansion of the healthcare sector in emerging economies,...